drugset / Trial / NCT00368108

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00368108

Phase 3 Completed 752 enrolled Eisai Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.

Timeline

Start
2006-08
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule 2 mg Oral
Subject Perampanel Small molecule 4 mg Oral

Indications